Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02283658
Title Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Mayo Clinic
Indications

fallopian tube carcinoma

peritoneal carcinoma

ovarian carcinoma

Therapies

Everolimus + Letrozole

Age Groups: adult
Covered Countries USA


No variant requirements are available.